Martha Louzada

Development of a Clinical Prediction Rule for Risk Stratification of Recurrent Venous Thromboembolism in Patients With Cancer-Associated Venous Thromboembolism

Martha Louzada, Marc Carrier, Alejandro Lazo‐Langner et al. · Circulation · 2012 · 226 citations · Full text

Medicine, Oncology, Cancer Epidemiology +15

A prospective study of Rivaroxaban for central venous catheter associated upper extremity deep vein thrombosis in cancer patients (Catheter 2)

Gwynivere A Davies, Alejandro Lazo‐Langner, Esteban Gándara et al. · Thrombosis Research · 2017 · 97 citations

Medicine, Oncology, Pharmacotherapy +15

Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial

Meletios Α. Dimopoulos, Paul G. Richardson, Nizar J. Bahlis et al. · The Lancet Haematology · 2022 · 47 citations

Medicine, Oncology, Pharmacotherapy +12

Predicting the risk of recurrent venous thromboembolism in patients with cancer: A prospective cohort study

Nick van Es, Martha Louzada, Marc Carrier et al. · Thrombosis Research · 2018 · 42 citations

Medicine, Oncology, Clinical Epidemiology +11

Clinical performance of bleeding risk scores for predicting major and clinically relevant non‐major bleeding events in patients receiving warfarin

Sarag Burgess, Natalie Crown, Martha Louzada et al. · Journal of Thrombosis and Haemostasis · 2013 · 36 citations

Medicine, Clinical Sciences, Internal Medicine +14